News | November 14, 2006

Intermountain Healthcare and GE Healthcare Form Alliance for Clinical Content Development

Together, GE Healthcare and Intermountain are working to help enhance patient care by accelerating the adoption of electronic health records and the use of evidence-based medicine and other forms of best practice among health systems in the U.S.
As part of the new agreement, GE and Intermountain will work together to enhance the Centricity Enterprise Solution by developing and incorporating standardized vocabulary and clinical element models that will help enable the use of clinical data, such as protocols for optimal use of antibiotics, providing clinicians with critical decision support tools at the point of care. 
 “It’s about bringing science from the research arena to the bedside quicker,” said Mark Dente, MD and vice president of Healthcare Solutions for GE Healthcare Integrated IT Solutions. “Today the amount of time it takes for the widespread adoption of the latest medical treatments and protocols is entirely too long, but with the use of information technology we can make the latest medical information breakthroughs accessible and easier for physicians, nurses and others to implement.”
“It is time we made use of breakthrough science, best clinical practices and evidence-based medicine to improve patient care and reduce medical errors by making it available and actionable for physicians and patients during routine visits,” said David Burton, vice president for Health Delivery Research at Intermountain Healthcare. “Beginning with standardized terminology, we will lay the foundation of a common language so that physicians, nurses and other bedside caregivers will have the latest guidelines available in the clinic and at the bedside,” said Burton.

Related Content

New Guideline Published for Evaluation of Valvular Regurgitation After Catheter-based Valve Interventions
News | Cardiovascular Ultrasound | April 30, 2019
A new document compiled by four cardiac imaging professional societies provides a resource to guide clinicians in best...
Six Predictions on How the Ultrasound Systems Market Will Expand Through 2022
News | Ultrasound Imaging | April 26, 2019
With healthcare costs continuing to rise, affordable and accurate imaging and diagnosis achieved through ultrasound...
Ebit and DiA Imaging Analysis Partner on AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | April 16, 2019
DiA Imaging Analysis has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo...
360 Photos | 360 View Photos | April 12, 2019
This 360 degree view shows staff at the ...
DiA Imaging Analysis Introduces LVivo SAX Ultrasound Analysis Tool
Technology | Cardiovascular Ultrasound | April 09, 2019
DiA Imaging Analysis announced the launch of LVivo SAX, a cardiac analysis tool that helps clinicians quickly and...
Bay Labs Announces New Data on EchoGPS, AutoEF AI Software at ACC.19
News | Cardiovascular Ultrasound | March 15, 2019
Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the...
Canon Medical Systems introduces 33 MHz Ultra-High Frequency Ultrasound Transducer
News | Ultrasound Imaging | March 01, 2019
March 1, 2019 — Expanding its advanced, high-performing Aplio i-series...
Philips Launches Latest Iteration of IntelliSpace Cardiovascular at HIMSS 2019
Technology | Cardiac PACS | February 13, 2019
Philips announced the launch of IntelliSpace Cardiovascular 4.1, its next-generation cardiovascular image and...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi